Skip to content
Home/Companies/Pharma/itm (ITM)

itm (ITM)

Pharma·Germany·Exited 2026·Held 8yr
Entry
2018
Hold
8yr
Exit
2026

Who owns itm (ITM)?

itm (ITM) is a German Pharma company, now owned by Telix Pharmaceuticals, which acquired it in 2026 from Capmont.

Hand-verified · updated 2026-07-03

Open JSON · CC-BY
Capmont
Investor
Capmont
Capmont Private Equity · 2006 · Evergreen

Key facts

HQGermany
SectorPharma
StatusActive
Exit Type
Trade Sale
Buyer
Telix Pharmaceuticals Limited
Exit Year
2026

More from Capmont Private Equity

Other portfolio companies in the same fund.

Dyneon
Active
IndustrialsGermany· 2026
Binetti Cablaggi
Active
IndustrialsItaly· 2025
Deutsche Fertighaus Holding
Active
ConsumerGermany· 2025
Liposphere
Liposphere
Active
MedTechGermany· 2025
Quad Europe
Active
Business ServicesGermany· 2025
Rockfin
Rockfin
Active
EnergyPoland· 2025

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alcala Farma
Active
Advent InternationalSpain
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS

Questions

Who owns itm (ITM)?

itm (ITM) is now owned by Telix Pharmaceuticals, which acquired it in 2026 from Capmont.

When did Telix Pharmaceuticals acquire itm (ITM)?

Telix Pharmaceuticals acquired itm (ITM) in 2026, buying from Capmont.

Who did itm (ITM) sell to?

Capmont sold itm (ITM) to Telix Pharmaceuticals in 2026 (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue